Browse hierarchy: [Gastroenterology, Urology (GU)](/submissions/GU) → [Subpart F — Therapeutic Devices](/submissions/GU/subpart-f%E2%80%94therapeutic-devices) → [21 CFR 876.5983](/submissions/GU/subpart-f%E2%80%94therapeutic-devices/876.5983) → QTD — Endoscopic Suturing Device For Altering Gastric Anatomy For Weight Loss

# QTD · Endoscopic Suturing Device For Altering Gastric Anatomy For Weight Loss

_Gastroenterology, Urology · 21 CFR 876.5983 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/QTD

## Overview

- **Product Code:** QTD
- **Device Name:** Endoscopic Suturing Device For Altering Gastric Anatomy For Weight Loss
- **Regulation:** [21 CFR 876.5983](/submissions/GU/subpart-f%E2%80%94therapeutic-devices/876.5983)
- **Device Class:** 2
- **Review Panel:** [Gastroenterology, Urology](/submissions/GU)
- **Implant:** yes

## Identification

This endoscopic device uses suturing to approximate gastric tissue to restrict the volume of the stomach for the intended purpose of weight loss.

## Recent Cleared Devices (2 of 2)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [K232544](https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/QTD/K232544.md) | Apollo ESG NXT System, Apollo REVISE NXT System | Apollo Endosurgery, Inc. | Sep 18, 2023 | SESE |
| [DEN210045](https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/QTD/DEN210045.md) | APOLLO ESG System, APOLLO ESG SX System, APOLLO REVISE System, APOLLO REVISE SX System | Apollo Endosurgery, Inc. | Jul 12, 2022 | DENG |

## Top Applicants

- Apollo Endosurgery, Inc. — 2 clearances

---

**Source:** [https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/QTD](https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/QTD)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com